Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels

Gang Huang(Shanghai Jiao Tong University), Mengchao Wu(Second Military Medical University), Ze‐Ya Pan(Second Military Medical University), Wan Yee Lau(Chinese University of Hong Kong), Shengxian Yuan(Second Military Medical University), Weiping Zhou(Second Military Medical University), Feng Shen(Second Military Medical University)
JAMA Surgery
April 2, 2014
10.1001/jamasurg.2013.4648
Cited by 57

Related Papers

Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
|PubMed|1999|519
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335